Table 2.
Baseline metabolic and haemodynamic assessments in all four experimental groups in the 24 h (day −1) prior to initiation of intermittent hypoxia (IH) or intermittent air (IA) exposure and infusion protocols
| IA + saline | IH + saline | IA + glucose | IH + glucose | |
|---|---|---|---|---|
| Sample size (n) | 13 | 17 | 14 | 14 |
| Age (days) | 76 ± 4 | 75 ± 2 | 76 ± 3 | 74 ± 1 |
| Body weight (gm) | 23.6 ± 0.6 | 23.2 ± 0.4 | 23.2 ± 0.6 | 23.2 ± 0.5 |
| Blood pressure (mmHg) | 103 ± 2 | 104 ± 1 | 102 ± 1 | 104 ± 2 |
| Blood glucose (mg dl−1) | 117 ± 2 | 113 ± 2 | 110 ± 3 | 107 ± 4 |
| Plasma insulin (ng ml−1) | 1.4 ± 0.2 | 1.4 ± 0.2 | 1.7 ± 0.3 | 1.2 ± 0.2 |
| Plasma corticosterone (ng ml−1) | 52 ± 14 | 52 ± 7 | 53 ± 13 | 51 ± 14 |